Lakewood-Amedex Biotherapeutics Inc. - 8-K Filing

Lakewood-Amedex Biotherapeutics Inc. receives Nasdaq delisting notice due to bid price falling below $1.00 for 30 consecutive business days. (Items: 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $LABT

Read the full article at SEC EDGAR

Part of the story Lakewood-Amedex Biotherapeutics Inc. - 8-K Filing (2 articles)

More Regulatory news